A common challenge for physicians prescribing GLP-1s is whether to increase the dose of Trulicity or switch patients to Mounjaro when managing uncontrolled Type 2 diabetes, according to the ...

Ozempic cut the HbA1C of patients by 1.5% compared with 1.1% by Trulicity at the low dose, and 1.8% compared with 1.4% at the high dose, with more patients hitting their target. Last week’s ...